Molecular Health GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Molecular Health GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11147
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Molecular Health GmbH (Molecular Health) is a biomedical company that designs, develops, manufactures and commercializes software systems which performs integrated analysis of clinical and genomic patient data to support treatment decisions and provide related services. The company offers Molecular Health Guide (MH Guide), an in vitro diagnostic medical device that analyzes and interprets tumors. It provides Dataome technology platform to interpret the molecular and clinical data of individual patients with reference to the world’s biological, pharmacological and medical knowledge, for accurate therapeutic, diagnostic, and drug safety decisions. The company is funded by Dievini Hopp BioTech. It has presence in Germany and the US. Molecular Health is headquartered in Heidelberg, Germany.

Molecular Health GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Health GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Molecular Health GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Molecular Health Raises USD27 Million in Venture Financing 11
MolecularHealth Raises Venture Financing From dievini Hopp BioTech 12
Partnerships 13
Molecular Health Enters into Distribution Agreement with TestAnalytika 13
Molecular Health GmbH – Key Competitors 14
Molecular Health GmbH – Key Employees 15
Molecular Health GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
May 16, 2018: Molecular Health to pursue drug repurposing in tuberculosis treatment and perinatal complications 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Molecular Health GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Health GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Health GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Molecular Health GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Molecular Health Raises USD27 Million in Venture Financing 11
MolecularHealth Raises Venture Financing From dievini Hopp BioTech 12
Molecular Health Enters into Distribution Agreement with TestAnalytika 13
Molecular Health GmbH, Key Competitors 14
Molecular Health GmbH, Key Employees 15
Molecular Health GmbH, Subsidiaries 16

List of Figures
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Health GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Molecular Health GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Molecular Health GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DZ HYP AG:企業の戦略・SWOT・財務分析
    DZ HYP AG - Strategy, SWOT and Corporate Finance Report Summary DZ HYP AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Inova Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include QUANTA Flash used for semi-quantitative determination of aut …
  • LM Wind Power Holding AS-エネルギー分野:企業M&A・提携分析
    Summary LM Wind Power Holding AS (LM Wind Power), a subsidiary of General Electric Co, is a component supplier to the wind industry. The company designs and manufactures blades on modular technology featuring modular aerodynamics, modular structure and modular manufacturing tooling. Its blades have …
  • Grupo Financiero Galicia S.A. (GGAL3):企業の財務・戦略的SWOT分析
    Grupo Financiero Galicia S.A. (GGAL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bracco SpA:企業の戦略的SWOT分析
    Bracco SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • The Reject Shop Limited (TRS):企業の財務・戦略的SWOT分析
    The Reject Shop Limited (TRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • POET Technologies Inc (PTK):電力:M&Aディール及び事業提携情報
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company provides products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among …
  • Clinical Innovations LLC:医療機器:M&Aディール及び事業提携情報
    Summary Clinical Innovations LLC (Clinical Innovations), a portfolio company of EQT AB, is a medical device company that researches and manufactures healthcare products to improve the lives of mothers and their babies. The company focuses on labor, delivery and neonatal intensive care. Its major pro …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Microsoft Corporation:企業のM&A・事業提携・投資動向
    Microsoft Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microsoft Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Ajman Bank (AJMANBANK):企業の財務・戦略的SWOT分析
    Ajman Bank (AJMANBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • AVX Corp (AVX):企業の財務・戦略的SWOT分析
    AVX Corp (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Avon Rubber Plc (AVON):企業の財務・戦略的SWOT分析
    Avon Rubber Plc (AVON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bostwick Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bostwick Laboratories Inc (Bostwick) is a medical laboratory that focuses on the interpretation of prostate and urological biopsies. The company offers services such as client services, clinical services, urologic laboratory services, and subspecialty laboratory services. Its urologic labora …
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Enel SpA (ENEL):企業の財務・戦略的SWOT分析
    Enel SpA (ENEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Petrogrand AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrogrand AB (Petrogrand), formerly Malka Oil AB is an oil and gas company that acquires, explores and produces crude oil and natural gas assets. The company carries out management and refining of Russian oil assets. It holds interests in the Nizhne-Paninsky license area located in northwes …
  • BioScrip Inc (BIOS)-医療機器分野:企業M&A・提携分析
    Summary BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that offers infusion care services. The hospital provides a range of infusion services, PBM services and respiratory services. Its infusion therapy services include antimicrobial drugs, factor replacement therapy for …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務分析
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆